Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Molecular Cancer Therapeutics
|
February 6, 2021
Correction: Combined Inhibition of NEDD8-activating Enzyme and mTOR Suppresses NF2 Loss-driven Tumorigenesis
Jonathan Cooper, Qingwen Xu, Lu Zhou, et al.
Cancer Medicine
|
February 4, 2023
Clinical value of second opinions in oncology: A retrospective review of changes in diagnosis and treatment recommendations
Allison Lipitz-Snyderman, Susan Chimonas, Sham Mailankody, et al.
Molecular Cancer Therapeutics
|
May 5, 2017
Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses <i>NF2</i> Loss-Driven Tumorigenesis
Jonathan Cooper, Qingwen Xu, Lu Zhou, et al.
Cancer
|
October 6, 2005
Developing a cancer-specific geriatric assessment: a feasibility study
Arti Hurria, Supriya Gupta, Marjorie Zauderer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 1, 2025
Safety and Tolerability of Lete-cel in NSCLC-Reply
Mehmet Altan, Gilberto Lopes, T Jeroen N Hiltermann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 22, 2024
Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non-Small Cell Lung Cancer
Mehmet Altan, Gilberto Lopes, T Jeroen N Hiltermann, et al.
The Oncologist
|
June 2, 2016
Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization
Siraj M Ali, Thomas Hensing, Alexa B Schrock, et al.
International Journal of Cancer
|
January 26, 2017
Alcohol and lung cancer risk among never smokers: A pooled analysis from the international lung cancer consortium and the SYNERGY study
Gordon Fehringer, Darren R Brenner, Zuo-Feng Zhang, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Molecular Cancer Therapeutics
|
February 6, 2021
Correction: Combined Inhibition of NEDD8-activating Enzyme and mTOR Suppresses NF2 Loss-driven Tumorigenesis
Jonathan Cooper, Qingwen Xu, Lu Zhou, et al.
Cancer Medicine
|
February 4, 2023
Clinical value of second opinions in oncology: A retrospective review of changes in diagnosis and treatment recommendations
Allison Lipitz-Snyderman, Susan Chimonas, Sham Mailankody, et al.
Molecular Cancer Therapeutics
|
May 5, 2017
Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses <i>NF2</i> Loss-Driven Tumorigenesis
Jonathan Cooper, Qingwen Xu, Lu Zhou, et al.
Cancer
|
October 6, 2005
Developing a cancer-specific geriatric assessment: a feasibility study
Arti Hurria, Supriya Gupta, Marjorie Zauderer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 1, 2025
Safety and Tolerability of Lete-cel in NSCLC-Reply
Mehmet Altan, Gilberto Lopes, T Jeroen N Hiltermann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 22, 2024
Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non-Small Cell Lung Cancer
Mehmet Altan, Gilberto Lopes, T Jeroen N Hiltermann, et al.
The Oncologist
|
June 2, 2016
Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization
Siraj M Ali, Thomas Hensing, Alexa B Schrock, et al.
International Journal of Cancer
|
January 26, 2017
Alcohol and lung cancer risk among never smokers: A pooled analysis from the international lung cancer consortium and the SYNERGY study
Gordon Fehringer, Darren R Brenner, Zuo-Feng Zhang, et al.
Page
of 2